Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-09-12 Renaud Ronald C JR Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2014-08-18 Maroni Bradley SVP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2014-07-28 Clayman Michael D. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2014-07-28 GOWEN MAXINE Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2014-05-14 Butler John P. President and CEO Grant or award · Stock Option (Right to Buy) +46,667 46,667
2014-05-14 Amello Jason SVP, CFO & Treasurer Grant or award · Stock Option (Right to Buy) +21,667 21,667
2014-05-14 Hadas Nicole R. VP General Counsel & Secretary Grant or award · Stock Option (Right to Buy) +16,667 16,667
2014-05-14 Shalwitz Robert Chief Medical Officer Grant or award · Stock Option (Right to Buy) +21,667 21,667
2014-03-25 Novartis Bioventures Ltd 10% owner Purchase +182,590 $17.00 $3.1M 182,590
2014-03-25 Novartis Bioventures Ltd 10% owner Conversion +3,223,174 3,405,764
2014-03-25 Novartis Bioventures Ltd 10% owner Conversion · Series A Convertible Preferred Stock −257,031 0
2014-03-25 Novartis Bioventures Ltd 10% owner Conversion · Series B Convertible Preferred Stock −347,831 0
2014-03-25 Novartis Bioventures Ltd 10% owner Conversion · Series C Convertible Preferred Stock −708,647 0
2014-03-25 WYZGA MICHAEL S Director Purchase +1,500 $17.00 $26K 1,500
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion +12,560 247,540
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion +17,016 264,556
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion · Series A Convertible Preferred Stock −850 0
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion · Series B Convertible Preferred Stock −2,070 0
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion · Series C Convertible Preferred Stock −2,500 0
2014-03-25 Shalwitz Robert Chief Medical Officer Conversion · Series A Convertible Preferred Stock −3,403 0

Page 29 of 30 · 590 trades